Cathinone increases body temperature, enhances locomotor activity, and induces striatal c-fos expression in the Siberian hamster

Neuroscience Letters

Volumn 559, Issue , 2014, Pages 34-38

  Jones, S ^a,b   Fileccia, E L ^a,c   Murphy, M ^a   Fowler, M J ^a   King, M V ^a   Shortall, S E ^a   Wigmore, P M ^a   Green, A R ^a   Fone, K C F ^a   Ebling, F J P ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

C fos; Cathinone; Hyperthermia; Khat; Locomotor activity; Striatum

Indexed keywords

CATHINONE; PROTEIN C FOS;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BODY TEMPERATURE MEASUREMENT; BODY WEIGHT; CENTRAL NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; CORE TEMPERATURE; CORPUS STRIATUM; FEMALE; FOOD INTAKE; FUNCTIONAL ASSESSMENT; HEAD TWITCH; IMMUNOHISTOCHEMISTRY; LOCOMOTION; NONHUMAN; PHODOPUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REARING; SUPRACHIASMATIC NUCLEUS; TELEMETRY;

C-FOS; CATHINONE; HYPERTHERMIA; KHAT; LOCOMOTOR ACTIVITY; STRIATUM;

ALKALOIDS; ANIMALS; BODY TEMPERATURE; CENTRAL NERVOUS SYSTEM AGENTS; CORPUS STRIATUM; CRICETINAE; GENES, FOS; MALE; MOTOR ACTIVITY; PHODOPUS; PROTO-ONCOGENE PROTEINS C-FOS; UP-REGULATION;

EID: 84890297407     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.11.032     Document Type: Article

References (26)

1. Bookout A.L., de Groot M.H., Owen B.M., Lee S., Gautron L., Lawrence H.L., Ding X., Elmquist J.K., Takahashi J.S., Mangelsdorf D.J. FGF21 regulates metabolism and circadian behavior by acting on the nervous system. Nat. Med. 2013, 19:1147-1152.
2. Broadley K.J. The vascular effects of trace amines and amphetamines. Pharmacol. Therapeut. 2010, 125:363-375.
3. Carson D.S., Hunt G.E., Guastella A.J., Barber L., Cornish J.L., Arnold J.C., Boucher A.A., McGregor I.S. Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addict. Biol. 2010, 15:448-463.
4. Docherty J., Green A. The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives. Brit. J. Pharmacol. 2010, 160:1029-1044.
5. Duffield G.E., Dickerson J.M., Alexander I.H., Ebling F.J. Ontogeny of a photic response in the suprachiasmatic nucleus in the Siberian hamster (Phodopus sungorus). Eur. J. Neurosci. 1995, 7:1089-1096.
6. Duffield G.E., Hastings M.H., Ebling F.J.P. Investigation into the regulation of the circadian system by dopamine and melatonin in the adult Siberian hamster (Phodopus sungorus). J. Neuroendocrinol. 1998, 10:871-884.
7. Duffield G.E., McNulty S., Ebling F.J.P. Anatomical and functional characterisation of a dopaminergic system in the suprachiasmatic nucleus of the neonatal Siberian hamster. J. Comp. Neurol. 1999, 408:73-96.
8. Ebling F.J., Alexander I.H., Urbanski H.F., Hastings M.H. Effects of N-Methyl-d-aspartate (NMDA) on seasonal cycles of reproduction, body weight and pelage colour in the male Siberian hamster. J. Neuroendocrinol. 1995, 7:555-566.
9. Ebling F.P., Maywood E., Staley K., Humby T., Hancock D., Waters C., Evant G., Hastings M. The role of N-Methyl-d-Aspartate-type glutamatergic neurotransmission in the photic induction of immediate-early gene expression in the suprachiasmatic nuclei of the Syrian hamster. J. Neuroendocrinol. 1991, 3:641-652.
10. Escorihuela R., Fernández-Teruel A., Gil L., Aguilar R., Tobeña A., Driscoll P. Inbred Roman high-and low-avoidance rats: differences in anxiety, novelty-seeking, and shuttlebox behaviors. Physiol. Behav. 1999, 67:19-26.
11. Feyissa A.M., Kelly J.P. A review of the neuropharmacological properties of khat. Prog. Neuro-Psychopha. 2008, 32:1147-1166.
12. Gabrielsson J., Green A.R. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology. J. Pharmacol. Exp. Ther. 2009, 331:767-774.
13. Green A.R., King M.V., Shortall S.E., Fone K.C.F. Lost in translation: preclinical studies on 3, 4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans. Brit. J. Pharmacol. 2012, 166:1523-1536.
14. Hargreaves G., Hunt G., Cornish J., McGregor I. High ambient temperature increases 3, 4-methylenedioxymethamphetamine (MDMA,ecstasy)-induced Fos expression in a region-specific manner. Neuroscience 2007, 145:764-774.
15. Kelly J.P. Cathinone derivatives: a review of their chemistry, pharmacology, and toxicology. Drug Test. Anal. 2011, 3:439-453.
16. Kitao N., Hashimoto M. Increased thermogenic capacity of brown adipose tissue under low temperature and its contribution to arousal from hibernation in Syrian hamsters. Am. J. Physiol-Reg. I 2012, 302:R118-R125.
17. Kovacs K.J. Measurement of immediate-early gene activation-c-fos and beyond. J. Neuroendocrinol. 2008, 20:665-672.
18. Motbey C.P., Hunt G.E., Bowen M.T., Artiss S., McGregor I.S. Mephedrone (4-methylmethcathinone,'meow'): acute behavioural effects and distribution of Fos expression in adolescent rats. Addict. Biol. 2012, 17:409-422.
19. Murphy M., Jethwa P.H., Warner A., Barrett P., Nilaweera K.N., Brameld J.M., Ebling F.J. Effects of manipulating hypothalamic triiodothyronine concentrations on seasonal body weight and torpor cycles in Siberian hamsters. Endocrinology 2012, 153:101-112.
20. Shortall S., Green A., Swift K., Fone K., King M. Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone-induced hypothermia. Brit. J. Pharmacol. 2013, 168:966-977.
21. Vaughan C.H., Bartness T.J. Anterograde transneuronal viral tract tracing reveals central sensory circuits from brown fat and sensory denervation alters its thermogenic responses. Am. J. Physiol.-Reg. I 2012, 302:R1049-R1058.
22. Wood D.M., Dargan P.I. Mephedrone (4-methylmethcathinone): What is new in our understanding of its use and toxicity. Prog. Neuro-Psychopha. 2012, 39:227-233.
23. Wood D.M., Davies S., Puchnarewicz M., Button J., Archer R., Ovaska H., Ramsey J., Lee T., Holt D.W., Dargan P.I. Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J. Med. Toxicol. 2010, 6:327-330.
24. ACMD Consideration of the cathinones. Home Office report 2010, http://www.homeoffice.gov.uk/publications/agencies-public-bodies/acmd1/acmd-cathinodes-report-2010?view=Standard&pubID=878838 (accessed 22 July 2013).
25. EMCDDA Report on the Risk Assessment of Mephedrone in the Framework of the Council Decision on New Psychoactive Substances 2011, http://www.emcdda.europa.eu/html.cfm/index116639EN.html (accessed 22 July, 2013).
26. Press release, Home Office Khat to be Made a Class C Drug 2013, https://www.gov.uk/government/news/khat-to-be-made-a-class-c-drug (accessed 11 September 2013).